Philips Respironics reaches agreement with US government on a consent decree creating a clear path forward 10-04-2024, 13:05

On the 50th Anniversary of the First Mobile Phone Call, New Study Finds People Would Rather Give Up The Gym, Sports, Netflix — Even Sex — Than Their Phone 3-04-2023, 16:59

Io Therapeutics, Inc., presented today results from studies of IRX4204, the company’s phase II clinical development stage, highly selective RXR nuclear receptor agonist compound, supporting its potential use for treatment of amyotrophic lateral sclerosis 16-07-2024, 20:26